|
|
|
Real Estate News Releases
|
(EMAILWIRE.COM, March 07, 2012 ) Belize City, Belize -- Publishers of daily newsletter xtremepicks.com (http://www.xtremepicks.com) looks at Cannabis Science (CBIS)
Direct Global Media’s recent revised report on DROP (DEGH) – http://www.xtremepicks.com/reports/degh rallied big time when they released their price target, jumping as much as 20,000% and exactly hitting their $1.25 target – when Direct Global Media puts out their report, people listen.
Read CBIS research report that was released this weekend
Visit xtremepicks.com to get the CBIS research report FREE.
For additional information on this report or advertising inquiries, contact http://www.directglobalmedia.com at contact@directglobalmedia.com
Article except: ” It doesn’t take a rocket scientist to realize that this industry is growing and that there are untold riches to be made here,” said Troy Dayton, the chief executive of the ArcView Group.”
CLICK HERE FOR THE REPORT
Be sure to watch xtremepicks discussion on their Twitter and Facebook sites and definitely join the discussions with their new SKYPE Chat Room
ItÂ’s free, and itÂ’s easy to join. Skype can be downloaded at http://www.skype.com/intl/en-us/get-skype
Skype name: xtremepicks
CBIS closed Monday at $0.15 up 18.11% with heavy trading showing solid liquidity in the market. Members following xtremepicks $0.04 price alert are up close to 300%+ gains. News today by the company just goes to show you that they are looking at “blue skies” ahead and a step closer to a bullish breakout.
CBIS Chart
Cannabis Science Targets Opportune Immediate European Expansion With Acquisitions & Licensing Deals; Negotiations For First European Deal Is In Final Stages For New Products, Revenues, and Management
Cannabis Science, Inc. (OTCBB:CBIS.ob), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce final negotiations to target an immediate European expansion with opportune acquisitions & licensing deals. This new set of deals is designed to bring to bring new products, revenues, and executive management to the companyÂ’s growing operations. The target European company has already created its footprint distributing its products in the European Markets and around the world while meeting Cannabis ScienceÂ’s standards to ensure the utmost quality control and stringent procedures. more
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
About Xtremepicks.com
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep you informed of the latest movers.
Xtremepicks.com penny stock newsletter is your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. . Xtremepicks received no compensation for CBIS and may be buyers in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved
Directglobalmedia.com
Max Gordon
6479227508
contact@directglobalmedia.com 
|
|
|
|
Real Estate News by Sector
|
|
|
|
|
